• Kevin R J Schroth, Cristine D Delnevo, and Andrea C Villanti.
• Rutgers Center for Tobacco Studies, New Brunswick, NJ, United States of America; Department of Health Behavior, Society and Policy, Rutgers School of Public Health, Piscataway, NJ, United States of America. Electronic address: schrothk@cts.rutgers.edu.
• Prev Med. 2022 Dec 1; 165 (Pt B): 107197107197.

AbstractFor the first time since Congress authorized the U.S. Food and Drug Administration (FDA) to regulate tobacco in 2009, FDA proposed two tobacco product standards on May 4, 2022. After a period of public comment and agency review, if the product standards are finalized in their current form, they will ban menthol cigarettes (U.S. Food and Drug Administration, 2022b), which comprised 37% of the U.S. cigarette market in 2019 and 2020 (Federal Trade Commission, 2021), and flavored cigars (U.S. Food and Drug Administration, 2022a), which have exceeded 50% of cigar sales since 2012 (Delnevo et al., 2021b). This commentary examines potential challenges to banning flavored cigars and highlights issues FDA and Congress should consider.Copyright © 2022 Elsevier Inc. All rights reserved.

14 keywords...

hide…